NCT04131829View on ClinicalTrials.gov

Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 14, 2019

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Obsessive-Compulsive Disorder
Interventions
DRUG

Fluoxetine - immediate treatment

Following the Baseline assessment, OCD subjects will be randomized to receive either immediate fluoxetine monotherapy or delayed fluoxetine, after a 6-week placebo lead-in.

DRUG

Fluoxetine - delayed treatment

Following the Baseline assessment, OCD subjects will be randomized to receive either immediate fluoxetine monotherapy or delayed fluoxetine, after a 6-week placebo lead-in.

Trial Locations (1)

06519

RECRUITING

Yale OCD Research Clinic - CMHC/CNRU, 34 Park ST, New Haven

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Yale University

OTHER